Feed CASIF
Summary
43 / 100 · Bulios Score
Valuation 100Growth 9Profitability 22Quality 74Debt 0Stability 37
What speaks for it
- It earns 760 USD a year on every 100 USD of invested capital.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 1.8% a year over the last 3 years.
- It missed profit estimates 5 times in the last 6 quarters.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
2020202120222023202420262027
Diluted EPS (USD)
2020202120222023202420262027
- Analyst estimate
Revenue fell by 1.8% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $44.0M.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $3.77M
Debt $40.5M
Free cash flow over 12 months $0.00
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 6
- Hold 0
- Sell 0
Today's price within the analysts' price targets
Today's price $0.1 Average target $6
$0.1 $6
The average target of $6 is 5,894% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2019By product
- E V O M E L A 100%
By region
The company reports no revenue by region.
E V O M E L A brings in 100% of revenue.
Segments in detail